[Autoimmune hemolytic anemia following alpha-methyldopa therapy].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced*; D003298:Coombs Test; D003920:Diabetes Mellitus / Q000188:drug therapy; D005260:Female; D006801:Humans; D008750:Methyldopa / Q000009:adverse effects*; D008875:Middle Aged; D009393:Nephritis / Q000188:drug therapy; D013997:Time Factors; D014044:Tolbutamide / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D008750:Methyldopa; D014044:Tolbutamide
Autoimmunhämolytische Anämie im Gefolge einer Therapie mit alpha-methyl-dopa?